Limited data suggest that systematic risk assessment for CVD has no statistically significant effects on clinical endpoints .
There is limited evidence to suggest that CVD systematic risk assessment may have some favourable effects on cardiovascular risk factors .
BACKGROUND Screening programmes can potentially identify people at high cardiovascular risk and reduce cardiovascular disease ( CVD ) morbidity and mortality .
However , there is currently not enough evidence showing clear clinical or economic benefits of systematic screening-like programmes over the widely practised opportunistic risk assessment of CVD in primary care setting s. OBJECTIVES The primary objective of this review was to assess the effectiveness , costs and adverse effects of systematic risk assessment compared to opportunistic risk assessment for the primary prevention of CVD .
A controlled trial of multiphasic screening.
A clinical controlled trial was design ed to determine the impact of Automated Multiphasic Health Testing on morbidity and attitudes .  Three strata comprising 574 families ( lower-income group enrolled in health maintenance organization , lower-income not enrolled in such a project , and a middle-income group employed by a utility company ) were interviewed to obtain information on utilization , morbidity , health status , and attitudes .  Sixty percent of adults in each stratum were then screened . All families were interviewed again one year later . The only significant difference found between screened and non-screened subjects was an increase in nights hospitalized for screened subjects . Physicians were interviewed to determine what abnormalities were found and what treatment was required for project and privately referred patients of these physicians . Previously unknown abnormalities prompted retesting for confirmation in only 28 per cent of the cases and even less often led to treatment
Limited data suggest that systematic risk assessment for CVD has no statistically significant effects on clinical endpoints .
There is limited evidence to suggest that CVD systematic risk assessment may have some favourable effects on cardiovascular risk factors .
BACKGROUND Screening programmes can potentially identify people at high cardiovascular risk and reduce cardiovascular disease ( CVD ) morbidity and mortality .
However , there is currently not enough evidence showing clear clinical or economic benefits of systematic screening-like programmes over the widely practised opportunistic risk assessment of CVD in primary care setting s. OBJECTIVES The primary objective of this review was to assess the effectiveness , costs and adverse effects of systematic risk assessment compared to opportunistic risk assessment for the primary prevention of CVD .